Chemotherapy for melanoma - why is it not effective and what is its future?
Exciting randomized trials for mesothelioma: checkpoint inhibitor monotherapies and vinorelbine
Efficacy of pembrolizumab treatment in mucosal melanoma
UKONS at NCRI: how can trial access for young cancer patients be improved by nurses?
MSI as a biomarker in gynecological cancer